IFF has announced the launch of two new ingredients in its pet health portfolio, including Microsource CA, a microbiome-enhancing product for cat litter management, and Betafin Pet, a betaine ingredient to support dogs’ and cats’ hydration, gut health, and overall wellness.

“We’re excited to bring our world-class bioscience into the pet wellness space,” said Jordon Gruber, PhD, companion animal technical leader, Health & Biosciences, IFF. “Our new portfolio empowers brands to tackle key challenges, delivering standout products that enhance pet health and wellness in a competitive marketplace. From improving gut health and dental care to hydration and reducing odors, we are setting a new benchmark.”

IFF’s pet solutions are supported by specialized R&D centers, including the Pet Translational Research Lab in Wilmington, DE; the Pet Enzymes Lab in Brabrand, Denmark; and the Pet Applications Lab in New Century, Kansas, where clinical and application research takes place.

Microsource CA is a microbiome-enhancing product designed to improve cat litter management, with IFF internal data suggesting that seven days of use is associated with significant reductions in fecal ammonia. This ensures a cleaner and healthier environment free from harsh chemicals.

Betafin Pet, a naturally occurring betaine supports hydration, gut health, and overall wellness for both dogs and cats.

IFF’s pet health portfolio also includes enzymes, probiotics, plant protein, food protection solutions, natural colors, and flavors based on its proprietary flavor technology.

“This launch is more than the products; it’s about transforming the way we approach pet wellness,” said Brett Volmert, senior marketing leader for pets in North America. “Pet parents are increasingly focused on their pets’ health, and manufacturers require innovative, science-backed solutions, and a good understanding of functionality to meet this demand.”